Osmotica Pharmaceuticals plc to Provide Second Quarter 2021 Business and Financial Update on August 16, 2021
Osmotica Pharmaceuticals (Nasdaq: OSMT) will announce its 2021 second quarter financial results on August 16, 2021, after U.S. markets close. A conference call led by CEO Brian Markison, COO James Schaub, and CFO Andrew Einhorn will follow the announcement at 4:30 p.m. ET. Investors can access the call via toll-free numbers or international lines, and a replay will be available on the company’s website. Osmotica focuses on developing specialty products for underserved markets, operating in both the U.S. and Hungary.
- None.
- None.
BRIDGEWATER, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, today announced that the Company will release its 2021 second quarter financial results on Monday, August 16, 2021, after the close of the U.S. financial markets.
Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will host a conference call as follows:
| Date | Monday, August 16, 2021 | |
| Time | 4:30 p.m. ET | |
| Toll free (U.S.) | (866) 672-5029 | |
| International | (409) 217-8312 | |
| Conference ID | 1278168 | |
| Webcast (live and replay) | www.osmotica.com under the “Investor & News” section |
About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. RVL Pharmaceuticals, Inc. is the Company’s ophthalmic subsidiary supporting UPNEEQ®. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories, LLC represents the Company’s non-promoted products, including complex generic formulations.
Osmotica has operations in the United States and Hungary.
Investor and Media Relations for Osmotica Pharmaceuticals plc
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
FAQ
When will Osmotica Pharmaceuticals release its second quarter financial results?
What time is the Osmotica Pharmaceuticals conference call?
How can I access the Osmotica Pharmaceuticals conference call?
Where can I find the webcast for Osmotica Pharmaceuticals' conference call?
What is the focus of Osmotica Pharmaceuticals?
